Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients

(2010) R. Anty et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases

(2009) Minoru Satoh et al.   Modern Rheumatology

Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis

(2009) Yusuf Yilmaz et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

(2008) Naga P. Chalasani et al.   Contemporary Clinical Trials

Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis

(2008) Heather M. Patton et al.   GASTROENTEROLOGY

Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity

(2008) Enzo Emanuele   HEPATOLOGY